Angelos Spiliopoulos
Associate for Venture Development at Selvedge Venture- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English Native or bilingual proficiency
-
Greek Native or bilingual proficiency
Topline Score
Bio
Experience
-
Selvedge Venture
-
United Kingdom
-
Venture Capital and Private Equity Principals
-
1 - 100 Employee
-
Associate for Venture Development
-
Apr 2022 - Present
Selvedge Venture is a Venture Capital management and advisory firm with a focus on deep tech in life sciences and healthcare.
-
-
Business Analyst
-
Aug 2020 - Mar 2022
Researched, analysed and evaluated new and existing business opportunities.
-
-
-
-
Independent Consultant for academic group in Cell & Gene Therapy (C>)
-
Sep 2020 - Present
-
-
-
Exogene Ltd.
-
United Kingdom
-
Biotechnology
-
1 - 100 Employee
-
Chief Of Staff
-
Apr 2022 - Apr 2023
Mining the immune system for potent T-cell receptors, to develop cell therapies tackling solid tumors and immune aging. Mining the immune system for potent T-cell receptors, to develop cell therapies tackling solid tumors and immune aging.
-
-
-
Multiomic Health
-
United Kingdom
-
Biotechnology Research
-
1 - 100 Employee
-
Project Manager
-
Apr 2021 - Mar 2022
Multiomic Health is a next-generation precision medicine venture, integrating computational systems biology with laboratory science to develop and commercialize new therapeutics for metabolic syndrome — the world’s largest healthcare burden. During my time at Multiomic I researched, analysed and coordinated business aspects of scientific activities. Multiomic Health is a next-generation precision medicine venture, integrating computational systems biology with laboratory science to develop and commercialize new therapeutics for metabolic syndrome — the world’s largest healthcare burden. During my time at Multiomic I researched, analysed and coordinated business aspects of scientific activities.
-
-
-
SciTechStrategy
-
London, England, United Kingdom
-
Consultant Internship
-
Mar 2020 - Jun 2020
Thesis: Commercial Opportunity Assessment for a New Cell Therapy in Small Animal Oncology (Awarded with Certificate of Excellence for Best Dissertation Grade) Build commercial recommendations for a research team at the National University of Singapore by: • Identifying the most attractive large markets worldwide, with emphasis on canine and feline cancers • Researching how canine & feline cancer is treated • Investigating potential development & commercial partners • Estimating the market potential Show less
-
-
-
Imperial College London
-
Research Services
-
700 & Above Employee
-
Student Representative MSc Functional Omics/ Applied Genomics
-
Oct 2018 - Sep 2019
-
-
-
BSRC Alexander Fleming
-
Greece
-
Research Services
-
1 - 100 Employee
-
Summer Intern
-
Jun 2017 - Jul 2017
-Actively observed experts of specialised research in the field of immunology and genetics -Observed handling of transgenic mice and knockout mice as well as testing for the development of novel treatments of chronic inflammatory diseases -Presented up-to date publications related to the laboratory's thematology -Performed tissue sectioning in Paraffin embedded samples (microtome)/cryo-preserved samples (cryotome) and subsequently carried out H&E staining -Attended lectures and seminars on clinical and preclinical data acquired by all departments of the Center -Helped with the laboratories technical routine (i.e DNA isolation, PCR setting up, agarose gel preparation, DNA electrophoresis and DNA band analysis Show less
-
-
Education
-
University of Cambridge
Master of Philosophy - MPhil, Bioscience Enterprise -
Imperial College London
Master of Science - MS, Functional Omics/ Applied Genomics -
Kingston University
Bachelor of Science - BS, Biochemistry -
St. Lawrence College, Greece